Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 6/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 3/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL42339 | 0.95 | THRB (0.36) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL29854216 | 0.88 | THRB (0.37) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL10626911 | 0.84 | THRB (0.38) | THRBTSHRCA2HPGDTHRA | |
| SCHEMBL29649006 | 0.80 | THRB (0.32) | THRBPTPN1 | |
| SCHEMBL6435118 | 0.79 | THRB (0.36) | THRBCA2HSD17B10HPGDTHRA | |
| SCHEMBL4912293 | 0.77 | THRB (0.36) | THRBTSHRCA2HPGDTHRA | |
| SCHEMBL6437167 | 0.77 | THRB (0.32) | THRB | |
| SCHEMBL11393741 | 0.77 | THRB (0.35) | THRBTSHR | |
| SCHEMBL10440134 | 0.74 | THRB (0.40) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL30410456 | 0.74 | THRB (0.40) | THRBALDH1A1TP53CYP3A4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1009729-B1 | HALOGENATED ACRYLATES AND POLYMERS DERIVED THEREFROM | MINNESOTA MINING & MFG (US) | 2005-01-19 | — | — | EP | disclosed |
| US-6362379-B2 | ACRYLATES HAVING HIGH DEGREE OF HALOGENATION AND POLYMERS USING THESE MONOMERS; USEFUL FOR OPTICAL WAVEGUIDES AND TELECOMMUNICATION | 3M INNOVATIVE PROPERTIES COMPANY | 2002-03-26 | — | — | US | disclosed |
| US-6313245-B1 | USED IN OPTICAL DEVICES INCLUDING OPTICAL WAVEGUIDES AND INTERCONNECTING DEVICES | 3M INNOVATIVE PROPERTIES COMPANY | 2001-11-06 | — | — | US | disclosed |
| US-20010037028-A1 | Halogenated acrylates and polymers derived therefrom | 3M INNOVATIVE PROPERTIES COMPANY | 2001-11-01 | — | — | US | disclosed |
| US-6288266-B1 | HALOGENATED ACRYLATES OR THIOACRYLATES FOR POLYMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2001-09-11 | — | — | US | disclosed |
| EP-1009729-A1 | HALOGENATED ACRYLATES AND POLYMERS DERIVED THEREFROM | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 2000-06-21 | — | — | EP | disclosed |
| US-6005137-A | POLYMERS USED IN OPTICAL DEVICES INCLUDING OPTICAL WAVEGUIDES AND INTERCONNECTING DEVICES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 1999-12-21 | — | — | US | disclosed |
| WO-1998056749-A1 | HALOGENATED ACRYLATES AND POLYMERS DERIVED THEREFROM | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010037028-A1 | Halogenated acrylates and polymers derived therefrom | ZYX, ACR, ORMDL3 | THRB 3639/4885TSHR 1965/4885ALDH1A1 1042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.